461Curated trials
Enterprise Evidence Report · NR-REPORT-V2.0
Germany
Neuroscience Intelligence
Germany neuroscience evidence report: current clinical, research, institution and source-linked intelligence.
Evidence rank #6 of 50 · Data maturity A · Research score 50.6 · Data confidence 100.0 / 100 · Snapshot 2026-10-29 06:18 UTC.
94Recruiting trials
858Publications
447Institutions
Executive interpretation
Germany ranks #6 in the current NeuroRisk evidence-ranked market layer. This ranking summarizes indexed clinical, publication and institution evidence; it is not a probability of commercial success and not an investment recommendation.
Methodology status
Methodology NR-REPORT-V2.0. Clinical metrics and NCT evidence use only records classified as in_scope or related; out_of_scope records remain preserved outside these analytical counts. No synthetic ML confidence is presented as scientific probability. Counts and source links below are tied to the generation snapshot.
Methodology →Leading sponsors
Merck Sharp & Dohme LLC2311 recruiting
Charite University, Berlin, Germany192 recruiting
Hoffmann-La Roche164 recruiting
University Hospital Tuebingen101 recruiting
Ludwig-Maximilians - University of Munich103 recruiting
UCB Pharma90 recruiting
Novartis Pharmaceuticals91 recruiting
University Hospital Muenster90 recruiting
Boehringer Ingelheim90 recruiting
Pfizer81 recruiting
Disease activity
Parkinsons87trials
Epilepsy60trials
Alzheimers60trials
Stroke41trials
Other Neurology36trials
Depression26trials
Neuromuscular17trials
Multiple Sclerosis16trials
Adhd14trials
Other Psychiatry13trials
Research institutions
Research Center Borstel - Leibniz Lung CenterOpenAlexlinked institution
Competence Network Multiple SclerosisOpenAlexlinked institution
Max Planck Institute for ChemistryOpenAlexlinked institution
Berlin Center for Genomics in Biodiversity ResearchOpenAlexlinked institution
Chica and Heinz Schaller FoundationOpenAlexlinked institution
Dermatologikum HamburgOpenAlexlinked institution
Max Planck Institute for Empirical AestheticsOpenAlexlinked institution
Segeberger KlinikenOpenAlexlinked institution
Klinikum LippeOpenAlexlinked institution
Klinikum Links der WeserOpenAlexlinked institution
Clinical evidence trail
NCT07798674TreatHSP Platform: Adaptive Natural History Platform for Ataxias, HSPs, and Spastic AtaxiasRECRUITING
NCT07586150Personalized Pharmaco-Lifestyle Interventions for Severe Mental Illnesses (LIFETRAIN)NOT_YET_RECRUITING
NCT07544498XR2ESILIENCE - XR-Based Resilience Training for Stress and Mental Health in Healthcare WorkersNOT_YET_RECRUITING
NCT07476365A Multi-omic Approach to the Identification of Novel Biomarkers in Early Charcot-Marie-Tooth 1A Disease (CMT1A)RECRUITING
NCT07395206Acceptability, Feasibility and Preliminary Outcomes of the Kiso Mind App for Outpatients With Schizophrenia Spectrum DisordersRECRUITING
NCT07299448Biological Determinants and Neural Compensation of Dysphagia in Parkinson's DiseaseRECRUITING
NCT07212699Development of an Outcome Score for Patients With Knee Osteoarthritis and Knee Joint Endoprosthesis Using an AppRECRUITING
NCT07174310A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's DiseaseRECRUITING
Research evidence trail
PUBMEDMaternal depressive symptom trajectories in the first 12 postpartum months and the associated risk correlates.2027-01-01
PUBMEDMineralocorticoid receptor stimulation effects on stress-induced cortisol and alpha-amylase in female patients with borderline personality disorder and healthy controls: A randomized placebo-controlled experimental study.2027-01-01
PUBMEDGlioblastoma immune landscape remodeling following treatment with CD70-targeted CAR-T cells.2026-12-31
PUBMEDFrom gut to brain: data-driven evidence suggests causal contribution of gut-microbiota to major depressive disorder in humans.2026-12-31
PUBMEDFactors associated with long-term posttraumatic stress following later termination of pregnancy for fetal anomaly: results from a longitudinal study.2026-12-31
PUBMEDFeasibility and acceptability of modular empowerment group therapy in Ukrainian adult outpatients: A pilot study.2026-12-15
PUBMEDNegative expectations in major depression: Association with brain structure and course of illness.2026-12-15
PUBMEDFinancial counselling gaps in Alzheimer's care: Patient out-of-pocket expenses and physician barriers in a regional German cross-sectional pilot study.2026-12-01
PUBMEDDo subjective and objective baseline sleep disturbances predict post-traumatic stress disorder treatment response? A secondary analysis of a randomized controlled trial.2026-12-01
PUBMEDFunctional connectivity correlates of sequence memory decline in healthy older adults.2026-12-01
PUBMEDMechanistic characterization and inhibition of PAD4-dependent NETosis following experimental neonatal hypoxic-ischemic brain injury.2026-12-01
PUBMEDAssociations of childhood maltreatment types and timing with oxidative stress in formerly out-of-home placed young adults.2026-12-01
World Bank context
Macro indicators are shown only where a timestamped World Bank source row exists. Latest collection in this report: 2026-10-24 04:18 UTC. They are context, not NeuroRisk predictions.
Sources and provenance
ClinicalTrials.gov provides NCT evidence. PubMed/NCBI and OpenAlex provide research metadata. OpenAlex links institutions. World Bank indicators are included only when an explicit source row and year exist. NeuroRisk transformations add normalization, ranking and graph connections.
Limitations
Indexed corpus counts are not guaranteed exhaustive global totals. Scores are comparative decision-support signals. This report is not medical advice, regulatory advice, patent clearance, an investment recommendation or a guarantee of outcome.